We are live on ! Find out more
SLRN

ACELYRIN

Delisted

SLRN was delisted on the 21st of May, 2025.

105 hedge funds and large institutions have $183M invested in ACELYRIN in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 41 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $71K | Put options by funds: $31K

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

14.28% less ownership

Funds ownership: 87.69%73.41% (-14%)

16% less funds holding

Funds holding: 125105 (-20)

34% less capital invested

Capital invested by funds: $276M → $183M (-$93.8M)

46% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 41

48% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 42

Holders
105
Holders Change
-20
Holders Change %
-16%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
22
Reduced
41
Closed
42
Calls
$71K
Puts
$31K
Net Calls
+$40K
Net Calls Change
+$22K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$681K -$4.87M -2,047,706 -88%
SFI
27
Susquehanna Fundamental Investments
Pennsylvania
$675K +$85.5K +35,947 +15%
N
28
Nuveen
North Carolina
$500K
AQR Capital Management
29
AQR Capital Management
Connecticut
$478K +$460K +193,323 New
Wellington Management Group
30
Wellington Management Group
Massachusetts
$443K -$3.3K -1,389 -0.8%
Citadel Advisors
31
Citadel Advisors
Florida
$436K -$9.6M -4,035,479 -96%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$428K -$8.61K -3,622 -2%
SCM
33
Stonepine Capital Management
Oregon
$414K +$82.5K +34,710 +26%
Millennium Management
34
Millennium Management
New York
$369K -$10.9M -4,565,104 -97%
BCM
35
Bridgeway Capital Management
Texas
$348K +$335K +140,900 New
MAM
36
Monaco Asset Management
Monaco
$345K +$332K +139,600 New
William Blair & Company
37
William Blair & Company
Illinois
$342K
Franklin Resources
38
Franklin Resources
California
$314K +$86.7K +36,469 +40%
Los Angeles Capital Management
39
Los Angeles Capital Management
California
$271K -$29.5K -12,391 -10%
UBS Group
40
UBS Group
Switzerland
$256K -$198K -83,480 -45%
XT
41
XTX Topco
Cayman Islands
$255K +$220K +92,678 +894%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$252K -$14.4K -6,069 -6%
American Century Companies
43
American Century Companies
Missouri
$226K +$29.8K +12,522 +16%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$224K +$133K +55,845 +160%
Invesco
45
Invesco
Georgia
$211K +$142K +59,754 +232%
Barclays
46
Barclays
United Kingdom
$205K -$80.3K -33,773 -29%
AA
47
ALPS Advisors
Colorado
$184K -$15.4K -6,489 -8%
AllianceBernstein
48
AllianceBernstein
Tennessee
$182K
HIM
49
HGC Investment Management
Ontario, Canada
$174K +$167K +70,425 New
Deutsche Bank
50
Deutsche Bank
Germany
$152K -$20.1K -8,461 -12%

SLRN Hedge Fund Activity: Q1 2025 in Review

105 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in ACELYRIN (SLRN) for Q1 2025, worth a combined $183M — down 34% from $276M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of SLRN and 22 opened new positions — a net loss of 20 holders — while 41 trimmed existing stakes and 22 added.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $23.3M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $19.6M.

  • 105 institutional investors held ACELYRIN (SLRN) as of Q1 2025, down from 125 in Q4 2024.
  • Funds reported $183M of ACELYRIN stock for Q1 2025, down 34% quarter-over-quarter.
  • 22 funds opened new ACELYRIN positions in Q1 2025 and 42 closed out, a net change of -20 holders.
  • The largest ACELYRIN buyer in Q1 2025 was Tang Capital Management, an estimated $23.3M added.
  • The largest ACELYRIN seller in Q1 2025 was T. Rowe Price Investment Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2025.